By Lawrence Hurley
Daily Journal Staff Writer
This article appears on Page 1
WASHINGTON - Congress is scrutinizing former Los Angeles U.S. Attorney Debra Yang's role as a corporate monitor for one of five medical device manufacturers covered by a controversial deferred prosecution agreement.
The deal, brokered by New Jersey U.S. Attorney Christopher Christie, attracted headlines...
Daily Journal Staff Writer
This article appears on Page 1
WASHINGTON - Congress is scrutinizing former Los Angeles U.S. Attorney Debra Yang's role as a corporate monitor for one of five medical device manufacturers covered by a controversial deferred prosecution agreement.
The deal, brokered by New Jersey U.S. Attorney Christopher Christie, attracted headlines...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In